vs

Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

GREENPOWER MOTOR Co INC. is the larger business by last-quarter revenue ($7.2M vs $3.8M, roughly 1.9× Vivos Therapeutics, Inc.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -180.3%, a 114.6% gap on every dollar of revenue. On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs -11.5%).

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

GP vs VVOS — Head-to-Head

Bigger by revenue
GP
GP
1.9× larger
GP
$7.2M
$3.8M
VVOS
Growing faster (revenue YoY)
VVOS
VVOS
+14.9% gap
VVOS
3.4%
-11.5%
GP
Higher net margin
GP
GP
114.6% more per $
GP
-65.6%
-180.3%
VVOS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GP
GP
VVOS
VVOS
Revenue
$7.2M
$3.8M
Net Profit
$-4.7M
$-6.9M
Gross Margin
14.6%
78.1%
Operating Margin
-166.8%
Net Margin
-65.6%
-180.3%
Revenue YoY
-11.5%
3.4%
Net Profit YoY
-2.1%
-143.8%
EPS (diluted)
$-0.17
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GP
GP
VVOS
VVOS
Q4 25
$3.8M
Q3 25
$6.8M
Q2 25
$3.8M
Q1 25
$3.0M
Q4 24
$7.2M
$3.7M
Q3 24
$5.3M
$3.9M
Q2 24
$3.0M
$4.1M
Q1 24
$3.4M
Net Profit
GP
GP
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$-5.4M
Q2 25
$-5.0M
Q1 25
$-3.9M
Q4 24
$-4.7M
$-2.8M
Q3 24
$-4.7M
$-2.6M
Q2 24
$-5.4M
$-1.9M
Q1 24
$-3.8M
Gross Margin
GP
GP
VVOS
VVOS
Q4 25
78.1%
Q3 25
58.0%
Q2 25
55.2%
Q1 25
50.0%
Q4 24
14.6%
56.7%
Q3 24
8.6%
60.5%
Q2 24
7.4%
65.4%
Q1 24
56.7%
Operating Margin
GP
GP
VVOS
VVOS
Q4 25
-166.8%
Q3 25
-69.8%
Q2 25
-127.4%
Q1 25
-129.9%
Q4 24
-75.9%
Q3 24
-68.5%
Q2 24
-47.8%
Q1 24
-110.7%
Net Margin
GP
GP
VVOS
VVOS
Q4 25
-180.3%
Q3 25
-79.6%
Q2 25
-131.2%
Q1 25
-128.1%
Q4 24
-65.6%
-76.4%
Q3 24
-87.9%
-67.8%
Q2 24
-179.8%
-47.6%
Q1 24
-110.1%
EPS (diluted)
GP
GP
VVOS
VVOS
Q4 25
$-0.58
Q3 25
$-0.49
Q2 25
$-0.55
Q1 25
$-0.45
Q4 24
$-0.17
$0.41
Q3 24
$-0.18
$-0.40
Q2 24
$-0.21
$-0.60
Q1 24
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GP
GP
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$621.1K
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$2.1M
$-1.5M
Total Assets
$37.4M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GP
GP
VVOS
VVOS
Q4 25
$2.0M
Q3 25
$3.1M
Q2 25
$4.4M
Q1 25
$2.3M
Q4 24
$621.1K
$6.3M
Q3 24
$116.9K
$6.3M
Q2 24
$528.3K
$6.9M
Q1 24
$2.6M
Total Debt
GP
GP
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
GP
GP
VVOS
VVOS
Q4 25
$-1.5M
Q3 25
$2.5M
Q2 25
$4.6M
Q1 25
$4.4M
Q4 24
$2.1M
$8.0M
Q3 24
$4.2M
$7.7M
Q2 24
$8.6M
$6.3M
Q1 24
$582.0K
Total Assets
GP
GP
VVOS
VVOS
Q4 25
$25.2M
Q3 25
$25.6M
Q2 25
$26.0M
Q1 25
$11.3M
Q4 24
$37.4M
$15.3M
Q3 24
$39.4M
$15.3M
Q2 24
$43.5M
$15.8M
Q1 24
$11.8M
Debt / Equity
GP
GP
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GP
GP
VVOS
VVOS
Operating Cash FlowLast quarter
$-1.1M
$-3.8M
Free Cash FlowOCF − Capex
$-5.3M
FCF MarginFCF / Revenue
-139.7%
Capex IntensityCapex / Revenue
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GP
GP
VVOS
VVOS
Q4 25
$-3.8M
Q3 25
$-4.2M
Q2 25
$-3.5M
Q1 25
$-3.8M
Q4 24
$-1.1M
$-2.9M
Q3 24
$-1.3M
$-4.2M
Q2 24
$-3.2M
$-3.0M
Q1 24
$-2.5M
Free Cash Flow
GP
GP
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$-4.2M
Q2 25
$-4.3M
Q1 25
$-3.9M
Q4 24
$-3.1M
Q3 24
$-4.4M
Q2 24
$-3.1M
Q1 24
$-2.7M
FCF Margin
GP
GP
VVOS
VVOS
Q4 25
-139.7%
Q3 25
-62.6%
Q2 25
-111.6%
Q1 25
-129.9%
Q4 24
-84.0%
Q3 24
-113.4%
Q2 24
-76.7%
Q1 24
-78.0%
Capex Intensity
GP
GP
VVOS
VVOS
Q4 25
40.0%
Q3 25
1.2%
Q2 25
20.2%
Q1 25
4.0%
Q4 24
4.5%
Q3 24
5.0%
Q2 24
1.5%
Q1 24
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GP
GP

Segment breakdown not available.

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons